Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

PR Newswire
June 19, 2020 — 12:20 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Canada China chinese healthcare Hong Kong manufacturing stock exchange stock market Suzhou United States

Related News:

Tianliculum: Customizing Your Educational "Menu"

April 19, 2024 — 09:03

Automation Anywhere Earns 2024 Great Place To Work Certification™

April 18, 2024 — 22:00

Infosys to Acquire Leading Engineering R&D services provider, in-tech

April 18, 2024 — 21:42

National University of Singapore’s IES, The Rockefeller Foundation Advance Renewable Energy Connectivity in Southeast Asia

April 18, 2024 — 09:00

Students from JA Greece Win 2024 De La Vega Global Entrepreneurship Award

April 17, 2024 — 03:00

Bridgewise secures $21 million in new funding to support the global expansion of its AI-powered financial intelligence platform for global securities

April 16, 2024 — 12:01

International Film Camp Awards Winners

April 15, 2024 — 14:19

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

April 13, 2024 — 20:00

IOT Data Hackathon Award Ceremony – Data-driven Economy: Unleashing the Powerhouse of Possibilities

April 13, 2024 — 18:30